The weekly litigation news digest is live. Subscribe now

IP Verse

Purified Amphiphilic Peptide Compositions And Uses Thereof - EP3031466

The patent EP3031466 was granted to D Matrix on Nov 28, 2018. The application was filed on Jul 6, 2005 under application number EP15195734A. The patent is currently recorded with a legal status of "Revoked".

EP3031466

D MATRIX
Application Number
EP15195734A
Filing Date
Jul 6, 2005
Status
Revoked
Feb 2, 2024
Publication Date
Nov 28, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ARCH THERAPEUTICSAug 28, 2019POTTER CLARKSON -

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20010778200
DESCRIPTIONUS20040877068
DESCRIPTIONUS20040968790
DESCRIPTIONUS20050674612
DESCRIPTIONUS2004242469
DESCRIPTIONUS5670483
DESCRIPTIONUS5955343
EXAMINATIONWO2005014615
EXAMINATIONWO2006116524
OPPOSITIONEP1879606
OPPOSITIONJP2008509090
OPPOSITIONWO2006116524
OTHEREP1879606
OTHERWO2005014615
OTHERWO2006116524
SEARCHWO02062961
SEARCHWO03084980
SEARCHWO03096972

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents